These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10545538

  • 21. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 22. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
    Neylan JF.
    Transplantation; 1998 Feb 27; 65(4):515-23. PubMed ID: 9500626
    [Abstract] [Full Text] [Related]

  • 23. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
    Ulsh PJ, Yang HC, Holman MJ, Ahsan N.
    J Transpl Coord; 1999 Jun 27; 9(2):114-8. PubMed ID: 10703393
    [Abstract] [Full Text] [Related]

  • 24. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.
    Henry ML.
    Clin Transplant; 1999 Jun 27; 13(3):209-20. PubMed ID: 10383101
    [Abstract] [Full Text] [Related]

  • 29. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC, Azeka E, Trindade E, Galas FR, Hajjar LA, Benvenuti L, Riso A, Tanamati C, Penha J, Auler JO, Jatene M.
    Transplant Proc; 2012 Oct 27; 44(8):2483-5. PubMed ID: 23026625
    [Abstract] [Full Text] [Related]

  • 30. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun 27; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 31. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.
    Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintmalm G, LIS2T Study Group.
    Transplantation; 2004 Jun 15; 77(11):1632-8. PubMed ID: 15201658
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
    Onsager DR, Canver CC, Jahania MS, Welter D, Michalski M, Hoffman AM, Mentzer RM, Love RB.
    J Heart Lung Transplant; 1999 May 15; 18(5):448-55. PubMed ID: 10363689
    [Abstract] [Full Text] [Related]

  • 33. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E.
    Transplantation; 1997 Aug 15; 64(3):436-43. PubMed ID: 9275110
    [Abstract] [Full Text] [Related]

  • 34. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug 15; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 38. Neoral rescue therapy in transplant patients with intolerance to tacrolimus.
    Abouljoud MS, Kumar MS, Brayman KL, Emre S, Bynon JS, OLN-452 Study Group.
    Clin Transplant; 2002 Jun 15; 16(3):168-72. PubMed ID: 12010138
    [Abstract] [Full Text] [Related]

  • 39. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 15; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 40. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K, Davidson BR, Burroughs AK.
    Transplantation; 1999 Oct 27; 68(8):1195-8. PubMed ID: 10551650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.